York Pharma Share Discussion Threads

[topinfo] 22/7/2009 16:43

RA if youre looking in at this BB you cant just say nothing you know, money is due to ULU and we want to know what is happening to YRK, are you going under or are we going to get some of our money back?

[topinfo] 22/7/2009 16:12

Spineless management going to issue RNS near to close or after close of LSE today....Spineless Tw@ts....

[topinfo] 22/7/2009 16:12

Spineless management going to issue RNS near to close or after close of LSE today....Spineless Tw@ts....

[topinfo] 22/7/2009 12:04

RNS to come out today I reckon, I have written this off now. Anything else is bonus but looks like another Aim shafting. Sorry Guys.!!!

[topinfo] 22/7/2009 09:12

Well "D" Day has come and still no RNS from YRK, either RA has totally lost his bottle and run off from the company to hide his head in the sand or they are preparing one hell of an RNS to put out later.??...The lack of news seriously worries me now.

[topinfo] 22/7/2009 09:12

Well "D" Day has come and still no RNS from YRK, either RA has totally lost his bottle and run off from the company to hide his head in the sand or they are preparing one hell of an RNS to put out later.??...The lack of news seriously worries me now.

[topinfo] 21/7/2009 10:34

Yeah agree but whats taking so long...mkt cap tiny, this kind of deal could be sorted in days not months.

[nobbygnome] 21/7/2009 08:52

I think realistically they have longer than 30 days so patience is a virtue (as always)!

Nobby

[topinfo] 21/7/2009 08:47

Handy...Yes but if York cant pay them back that is effectively saying they have been unable to raise funds or complete merger...I hope they can pay them back and come back to the market much stronger but as the clock ticks I am starting now to count my losses here.

[handycam] 21/7/2009 08:40

ULU don't have the money to chase the debt!

[topinfo] 21/7/2009 07:23

Well it looks like RA ia taking it right to the wire with the repayment of the $1 million to ULU and sorting out all the other stuff, due by 22nd July (Tomorrow).

[topinfo] 20/7/2009 21:56

8Trade, thank you for those kind words, Im starting to like you again. I was very bullish on YRK and I have spoken on several occasions to someone at the company whilst shares suspended and although they didnt and couldnt give loads away due to FSA rules etc they hinted at being very optomistic. I hope my recent thoughts are unfounded but the longer it takes the more bearish I am becoming. I like most on here stand to lose and that gets me as this was once a great company and I thought RA could turn it around...maybe just maybe he will prove me wrong.?

[8trade] 20/7/2009 20:45

Strange but when i said to my friend that it dont look good with Tmn
and that you should worse case expect to lose all your money after it
was still suspended for 4 months it came back and rose 200% the same day.

They said nothing at all for 4 months too, not a word but it came out ok
in the end, of course that is a different company altogether but you can
always hope here.

[kiki14p] 20/7/2009 17:59

It's not looking good Topinfo, even you are no longer bullish. Maybe I am just pessimistic but ULU need to be paid this week and no announcement, rumours or anything speaks volumes imho, looks like I will have to admit to my mrs about losing a fair amount of our dosh. :(

[topinfo] 20/7/2009 12:05

Well I hate to say this but despite 4 months now of being bullish and believing what RA has said and what my source has said I am now having doubts about this supposed deal. This is taking far too long indeed for a company with a mkt cap so low. The payment due to ULU is in days and not one update in the past few weeks since YRK came out and told us the deal with ULU was off, and no update as to who they are fresh merger talks with etc. I trusted this new management and thought RA was genuine but it looks like another Aim shafting coming here as every day goes by with no news. If they had a deal to announce now would have been the perfect time to do with the mkts flying, but nothing at all announced. Poor show RA and I really do hope you prove us wrong and show us that you are not cut from the same cloth as the previous sh*te management.

[topinfo] 17/7/2009 11:22

Nobby. I also said the same, the deal with ULU was terminated as there was a better deal for shareholders which from my source was to be announced some time this week. It rather concerns me the time its taking to sort out but lets face it if everything was off and there was nothing left for the company to do they would have issued an RNS. Just remember banks were unwilling to refinance companies of late but that is all changing now with the economy shoing some signs of recovery and they will see future value in YRK at these levels and could get a very good return on their investment.

[nobbygnome] 16/7/2009 21:13

From my conversation with RA, there is absolutely no chance of YRK agreeing anything with Uluru. I can't elaborate further but this deal is definitely dead.

Nobby

[kiki14p] 16/7/2009 19:06

Uluru for the record in their original and as far as I am aware only offer offered 19.9m shares which at the time were worth $0.20 each which equates to $3.98million or at the rate then of 1.45:1 - £2.74million (approx 3.9p).

At todays price of $0.11 and rate of 1.64:1 would have equalled just £1.33million (approx 1.9p).

I don't think ULU's offer as stated was ever enough, but when talks were cancelled were probably worth less than 2.5p each per York share. Maybe ULU will come back with an improved offer as after all they are themselves desperate to add some revenue earning products to their product range/pipeline, and they are the ones who sold it to prostraken before it was sold to Crawford healthcare (laterly Derms Development) so will know the product well.

[kiki14p] 16/7/2009 18:57

JsMan.. the £500k per month is my guesstimate of total revenue for the company with Zindaclin making up approx a third of that. So maybe annual revenue for Zindaclin of c£2million. Having worked in the industry until recently if you were looking to acquire a product you would be looking to pay (dependent on gross margins on the product) of anywhere between 1.5 and 3 x annual revenues. From experience I would have expected Zindaclin to have reasonably good margins hence my guess at 2.5x revenues.

I've no doubt that Zindaclin has some value to it, as growth can come from sales from throughout europe and not just the UK plus York own the rights for the US, although it would need to undergo more clinical trials for approval there.

I would have thought a fellow listed company who can issue paper could pick up Zindaclin and the products under development on the cheap without having to dilute their shareholders too much. Imho.

[jsman] 16/7/2009 11:23

TopInfo, you seem for ever an optimist. Do you still think there's a deal and if so, why has it not been announced at what you say is a great time to do so? Instead, we are told, they can't find $1m + interest. Depending on the terms of the loan, ULU may go for one of YRK's successful products lines, which prompted their interest in the first instance. This may even turn out to be a cunning plan to benefit a few individuals and we get nothing.

The RNS seems to suggest some hope that ULURU could have some further interest in the company, perhaps at a better value.

kiki14p, is the 500k per month from Zindaclin profit or just revenue?

[topinfo] 16/7/2009 07:24

Kiki...You have been busy, sounds okay but I still think if deal with ULU was worth around 6p per share and RA thought this deal was much better for shareholders then I would assume a starting share price of well above that 6p figure IMHO.

[kiki14p] 16/7/2009 06:35

It appears to me that York still own one valuable asset Zindaclin. Anyone know the annual turnover for this product? The derms devt products had turnover of approx £500k per month before the s..t hit the fan - so say £6m per annum, at a guess Zindaclin may have accounted for a third of that so say £2 million. Considering as it is approved in most european countries and York owns the rights for the US it must surely be worth 2.5x sales i.e. £5 million.

The debt position is not so clear there is the £750k owed to ULU and say another £750k - total of £1.5 million. So maybe £3.5million to 'divi up' between shareholders.

If the debtholders (the key here imho - owed $6million) agree to be issued with c£10 million shares in exchange for the convertible debentures, there would be approx 70 million shares - £3.5million / 70 million shares = 5p. before anything for any other products in development - abasol etc which may or may not have any value. all imho.

[topinfo] 15/7/2009 20:13

I tell you what though Guys maybe just maybe their advisors have been trying to hold off announcing deal until some stability returned to the markets. What a belting time now to announce deal and relist shares. Dow up 500 points in last two sessions, markets flying around the world and investors piling back into stocks. If they announced deal now it will fly and thats for sure, maybe thats the reason for the delay.?

[kiki14p] 15/7/2009 19:28

The end result is nearly here imho, ULU are expecting $1 million plus interest by the end of next week. Can York conclude a deal or find the finance to pay back ULU by then? RA will keep things close to his chest so I don't think anyone knows for sure what is going to happen, I'm hoping things will come good but the longer it takes the less likely I think it will :(